substance-related disorders PART 2 opiates and depressants - dr krysiak

0.0(0)
studied byStudied by 9 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/59

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

60 Terms

1
New cards

what kind of opiates have the greatest abuse potential?

a. full agonist

b. antagonist

c. partial agonist

a.

2
New cards

list the opiate antagonists (bind to receptors but do not activate —> no effect)

naloxone

naltrexone

3
New cards

what is buprenorphine?

a. full agonist

b. antagonist

c. partial agonist

c.

4
New cards

what does SAMHSA recommend to assess addictive potential (opiates)?

current opioid misuse measure (COMM)

screener and opioid assessment for patients with pain (SOAPP)

5
New cards

what are the most important factors to consider in terms of addictive potential (opiates)?

  • prior history of substance abuse

  • family history of substance abuse

  • major psychiatric pathology

6
New cards

what screener for opiate addiction is based on potential for abuse PRIOR to starting therapy?

a. SOAPP

b. COMM

a.

7
New cards

what screener for opiate addiction is useful for patients ALREADY on chronic opiates?
a. SOAPP

b. COMM

b.

8
New cards

what is important to remember with COMM screening?

NOT A LIE DETECTOR

may have false positives and negatives

9
New cards

who is PDMP used by?

who is required to report?

  • prescribers

  • pharmacies — required reporting

  • law enforcement

  • monitoring/safety programs

10
New cards

how does acute opiate intoxication present?

  • decr. level of consciousness

  • may be combative

  • decr. respiratory drive

  • slurred speech

  • miosis

  • motor retardation

11
New cards

list signs of acute opiate intoxication

  • bradycardia

  • hypotension

  • hypothermia

  • sedation

  • miosis (pinpoint pupils)

  • hypokinesis (slowed movement)

  • slurred speech

  • head nodding

12
New cards

list nonpharm tx of opiate intoxication

  • place in a safe and monitored environment

  • decr. external stimulation and provide orientation and reality testing

  • monitor for signs and symptoms of respiratory depression

  • intubation may be required

13
New cards

what is the pharmacologic tx of opiate intoxication?

a. clonidine

b. benzodiazepines

c. naloxone

d. lofexidine

c.

14
New cards

what formulations of naloxone are given for take-home use? (SATA)

a. IV

b. IM

c. IN

b. c.

15
New cards

how often can we repeat the dose of naloxone?

what is the max dose?

repeat every 2-3 minutes until full reversal achieved

up to a total dose of 10 mg

16
New cards

when does the onset of opioid withdrawal typically occur?

17
New cards

list signs and symptoms of opioid withdrawal

think of it as the opposite of opiate intoxication

  • tachycardia

  • hypertension

  • hyperthermia

  • insomnia

  • mydriasis (enlarged pupils)

  • hyperreflexia

  • diaphoresis

  • piloerection

  • incr. respiratory rate

  • lacrimation

  • yawning

  • rhinorrhea

  • muscle spasms

  • abdominal cramps, N/V/D

  • bone and muscle pain

  • anxiety

18
New cards

how do we evaluate opiate withdrawal?

clinical opiate withdrawal scale (COWS)

19
New cards

list sx management options for opiate withdrawal

  • clonidine

  • lofexidine (lucemyra)

  • benzos

  • anti-emetics

  • muscle relaxants

    • as needed

20
New cards

what does clonidine decrease when used for opioid withdrawal?

what do we need to monitor?

decreases noradrenergic hyperactivity

-reduces nausea, vomiting, diarrhea, cramps, sweating

monitor BP and sedation

-hold dose BP <90/60

21
New cards

idk if we need to know

what dose of clonidine is initiated for opioid withdrawal?

0.1 mg PO TID

22
New cards

which of these meds to treat opioid withdrawal are alpha 2-adrenergic agonists? (SATA)

a. clonidine

b. lofexidine (lucemyra)

c. benzos

d. anti-emetics

e. muscle relaxants

a. b.

23
New cards

how long do we continue lofexidine for opioid withdrawal?

adverse effects?

what do we need to monitor?

continue for up to 14 days

adverse effects: hypotension, bradycardia, syncope, QT prolongation

monitor ECG in high-risk populations

monitor for electrolyte abnormalities

24
New cards

which of these requires hepatic dosing and is metabolized by CYP2D6?

a. clonidine

b. lofexidine

b.

25
New cards

list nonpharm tx for opioid use disorder therapy

  • support groups and counseling

  • combined with medications for best outcomes

26
New cards

list medications for opioid use disorder (MOUD)

  • agonist therapy

    • methadone

    • buprenorphine

    • heroin

  • antagonist therapy

    • naltrexone

27
New cards

methadone is primarily metabolized through ______ to inactive metabolite

CYP3A4

28
New cards

ex: antiretroviral drugs, rifampin

CYP3A4 inducers ______ levels of methadone

a. decrease

b. increase

a.

29
New cards

ex: azole fungals, macrolides (erythromycin)

CYP3A4 inhibitors ______ levels of methadone

a. decrease

b. increase

b.

30
New cards

when do we need and EKG if a patient is being put on methadone?

at what QTc level do we decrease dose or remove other causes?

EKG at baseline, 30 days, and then annually

QTc > 500 remove other causes or decrease dose

31
New cards

how do we dose methadone initially for OUD?

  • 20 mg PO daily

  • wait 2-4 hours

    • no withdrawal sx: continue as daily dose

    • withdrawal sx: give additional 5-10 mg dose

  • first total daily dose is limited to 40 mg

32
New cards

which of these treatments for OUD is a partial mu agonist and weak kappa antagonist?

a. methadone

b. buprenorphine

c. heroin

d. naltrexone

b.

33
New cards

which buprenorphine product comes as tablets and films?

a. buprenorphine (Subutex)

b. buprenorphine/naloxone (Suboxone)

b.

34
New cards

buprenorphine is metabolized by ______

CYP3A4

35
New cards

why did we combine bupernorphine with naloxone?

it prevents abuse basically somehow idk

it’s not absorbed when it’s taken as intended (SL)

36
New cards

do we need to wait after stopping opioids before starting buprenorphine?

YES — wait > 12 hours after last use

*usually wait till onset of withdrawal symptoms

37
New cards

how are patients usually monitored when on buprenorphine?

in office at 2-hour intervals until withdrawal symptoms are eliminated

38
New cards

which buprenorphine product would be equivalent to subutex 4 mg tablet?

a. subutex 4 mg film

b. suboxone 4/1 mg tablet

b.

different dosage forms are not equivalent

39
New cards

what OUD treatment requires a REMS program?

buprenorphine implant (Probuphine)

40
New cards

what patients are eligible for the buprenorphine implant (probuphine)?

  • sustained stability on transmucosal (SL) buprenorphine

  • on dose of ≤ 8 mg of SL tablet for ≥ 3 months

41
New cards

T/F many patients require life-long OUD therapy

TRUE

42
New cards

can anyone prescribe buprenorphine?

NO — must have special training and waiver

DEA number begins with “X”

43
New cards

do we need to wait for patients to be opioid free before starting naltrexone?

YES — wait 7-10 days

44
New cards

idk if we need to know

what oral dose of naltrexone may increase risk of liver damage?

> 50 mg

45
New cards

when does naltrexone require a REMS program?

injection

46
New cards

is naltrexone a controlled substance?

NO

47
New cards

how do we manage pain with opiate dependence?

use non-opioids and non-pharm options 1st for pain

single provider for any opiate use

48
New cards

how do we manage pain with opiate dependence if patients are not on methadone?

START METHADONE

49
New cards

how do we manage pain with opiate dependence if patients are on naltrexone?

  • won’t respond to opiate agonists

  • withhold naltrexone for 3-7 days after opiate

  • withhold naltrexone for 72 hours prior to opiate need

50
New cards

how do we manage pain with opiate dependence if patients are on buprenorphine?

  • consider high doses and/or more potent agonists (fentanyl)

  • consider adjunct options (BZD, ketamine)

  • if full agonist is needed: d/c buprenorphine

51
New cards

how should we treat pregnant patients with opiate abuse?

med therapy with an opioid agonist

52
New cards

what medications can we use in pregnancy with opiate abuse? (SATA)

a. methadone

b. buprenorphine

c. naltrexone

a. b.

53
New cards

T/F benzodiazepines do not typically cause life-threatening respiratory depression as a single agent

TRUE

54
New cards

list signs/symptoms of benzodiazepine intoxication

  • memory impairment

  • drowsiness

  • visual disturbances

  • confusion

  • GI distress

  • slurred speech

  • poor coordination

  • swaying

  • bloodshot eyes

55
New cards

how do we treat benzodiazepine intoxication?

flumazenil (romazicon)

56
New cards

list signs/symptoms of benzodiazepine withdrawal

  • agitation and restlessness

  • dizziness

  • flu-like sx

  • impaired memory and concentration

  • n/v

  • visual disturbances

  • convulsions

  • hallucinations

57
New cards

how do we treat benzodiazepine withdrawal?

benzo as replacement therapy and to prevent seizures

taper benzo over a long duration

58
New cards

what is the most commonly abused OTC medication?

dextromethorphan

59
New cards

what is known as “robodosing” or “robotripping”?

consuming large quantities of dextromethorphan to become intoxicated

may cause profound hallucinogenic effect

60
New cards

how do you treat dextromethorphan intoxication?

naloxone

but mixed efficacy